Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.210
+0.040 (3.42%)
Sep 24, 2026, 1:05 PM EDT - Market open
Immuron Market Cap
Immuron has a market cap or net worth of $10.46 million as of September 24, 2026. Its market cap has decreased by -7.45% in one year.
Market Cap
10.46M
Enterprise Value
4.24M
1-Year Change
-7.45%
Ranking
Category
Stock Price
$1.21
ChartMarket Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $10.46M, a decrease of -62.78%. That is a compound annual growth rate of -10.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 9.40M | 108.89% |
| Dec 31, 2025 | 4.50M | -53.61% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
| Jun 9, 2017 | 28.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enlivex | 11.19M |
| IN8bio | 10.84M |
| KALA BIO | 10.83M |
| Theriva Biologics | 10.77M |
| CytoMed Therapeutics | 10.77M |
| Purple Biotech | 10.76M |
| MetaVia | 10.74M |
| Adial Pharmaceuticals | 10.61M |